UNSPSC 51101667: Mepacrine or quinacrine

This classification denotes an antiprotozoal agent with the molecular formula C23H30ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0C805XYDE, chemically known as 1,4-pentanediamine, n4- (6-chloro-2-methoxy-9-acridinyl)-n1,n1-diethyl-, dihydrochloride but generally known as mepacrine, which bears US NIH Compound Identifier 237. European Medicines Agency schedules Mepacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08744MIG.

UNSPSC 51101667 Mepacrine or quinacrine is a Commodity code with minimal direct recent state and local procurement activity. The code nominally describes a specific antimalarial pharmaceutical, but recent opportunities tagged to this code show no actual solicitations for mepacrine or quinacrine. Instead, state and local governments have posted opportunities under this code for naloxone (an opioid reversal agent), generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, medical and first aid supplies for emergency response, and pharmacy benefit program consultation. This mismatch between the code's narrow pharmaceutical scope and the actual work being procured suggests that state and local procurement offices may be using this Commodity code as a catch-all for pharmaceutical and medical supply acquisitions that do not fit more precisely defined codes, or that the tagging is erroneous. The issuing bodies include state health and human services commissions, county health departments, municipal purchasing offices, and state cooperative purchasing alliances managing multi-jurisdictional pharmaceutical procurement.

Recent opportunities span Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with a July 26, 2023 response deadline and quarterly delivery to Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 seeking vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager channels. The City of Tampa issued IFB 26P00145 on March 25, 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a sheltered Small Local Business Enterprise set-aside with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted RFP S1070000015802 on January 20, 2026 for generic pharmaceuticals and OTC products to supply participating state and local facilities, with proposals due March 26, 2026 and product availability required by May 15, 2026. Given the code's narrow definition and the absence of actual mepacrine or quinacrine solicitations, the pursuit signal is weak unless your firm supplies the secondary products appearing in these opportunities.